|
Volumn 5, Issue 3, 2011, Pages 262-
|
Intentional infliximab use during pregnancy for severe steroid-refractory ulcerative colitis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
C REACTIVE PROTEIN;
HEMOGLOBIN;
INFLIXIMAB;
MESALAZINE;
METHYLPREDNISOLONE;
ABDOMINAL PAIN;
ADULT;
ANEMIA;
BIRTH WEIGHT;
CASE REPORT;
CESAREAN SECTION;
ERYTHEMA;
FEMALE;
FETUS DISTRESS;
FETUS HEART RATE;
GESTATION PERIOD;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
HYPOALBUMINEMIA;
INTESTINE MOTILITY;
INTESTINE ULCER;
LETTER;
PREGNANCY TERMINATION;
PREGNANT WOMAN;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
RECTUM HEMORRHAGE;
SIGMOIDOSCOPY;
ULCERATIVE COLITIS;
ULTRASOUND;
ADULT;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL;
COLITIS, ULCERATIVE;
FEMALE;
FETAL GROWTH RETARDATION;
HUMANS;
INFANT, NEWBORN;
INFANT, SMALL FOR GESTATIONAL AGE;
METHYLPREDNISOLONE;
PREGNANCY;
PREGNANCY COMPLICATIONS;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 79955947156
PISSN: 18739946
EISSN: 18764479
Source Type: Journal
DOI: 10.1016/j.crohns.2011.02.004 Document Type: Letter |
Times cited : (16)
|
References (5)
|